Related Experiment Videos
Coronary stenting with a balloon-expandable stent after the recanalization of chronic total occlusions
Catheterization and Cardiovascular Diagnosis
|April 1, 1992
Insights
The Palmaz-Schatz stent was implanted in six patients to reduce restenosis after coronary artery recanalization. Six-month follow-up showed no restenosis in five patients, indicating the stent
Area of Science:
- Interventional Cardiology
- Biomedical Engineering
- Vascular Biology
Background:
- Restenosis remains a significant challenge after coronary artery recanalization.
- Chronic total coronary occlusions (CTO) present unique recanalization difficulties.
- Minimizing restenosis is crucial for long-term patency and patient outcomes.
Observation:
- The Palmaz-Schatz stent was successfully implanted in six patients undergoing recanalization for CTO.
- All procedures were performed without major immediate complications.
- Angiographic follow-up was conducted at six months post-implantation.
Findings:
- One patient, who received two stents, showed asymptomatic restenosis at six months.
- The remaining five patients demonstrated no evidence of restenosis.
- This suggests a high degree of efficacy for the Palmaz-Schatz stent in preventing restenosis in this cohort.
Implications:
- The Palmaz-Schatz stent shows promise in reducing restenosis rates following CTO recanalization.
- Further research with larger cohorts is warranted to confirm these findings.
- Stent selection and implantation strategy may influence long-term outcomes in CTO interventions.
Abstract:
To diminish the restenosis rate after successful recanalization of chronic total coronary occlusion, we have implanted the Palmaz-Schatz stent in 6 patients. All procedures were successfully done without major complications. The angiographic follow-up at 6 months showed restenosis in one asymptomatic patient who had had 2 stents implanted. Five other patients had no evidence of restenosis.